Acetyl-cyclosporin A aldehyde is a chemically modified derivative of the immunosuppressive cyclic undecapeptide Cyclosporin A (CsA). This derivative is specifically functionalized at the (3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminobutyric acid (MeBmt) residue, where the hydroxyl group is acetylated and the terminal methyl group is oxidized to an aldehyde. This structural modification introduces a reactive aldehyde handle at a specific site on the CsA macrocycle. The primary application of this compound is as a key intermediate or precursor in the synthesis of novel cyclosporin derivatives and conjugates. The aldehyde functionality serves as a versatile chemical handle for further derivatization, enabling the attachment of various probes, linkers, or other functional groups via reductive amination or other coupling reactions. This is crucial in medicinal chemistry research for developing targeted drug delivery systems, creating fluorescently labeled probes for studying CsA's interaction with its target proteins (cyclophilins), or synthesizing bifunctional molecules for chemical biology studies. As a derivative of a well-known immunosuppressant, its research use is focused on exploring structure-activity relationships (SAR) and developing new therapeutic agents with potentially improved pharmacological profiles, such as reduced nephrotoxicity or enhanced target specificity. Handling requires standard precautions for peptide derivatives and reactive aldehydes.